AUGUST OLINGER: Open Payments
NPI 1396144523 · GRETNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 23 payments from 14 companies in 2025. Trend: 2023 $176 · 2024 $482 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 4 | $81 |
| Inspire Medical Systems, Inc. | 1 | $54 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Amgen Inc. | 3 | $44 |
| Lilly USA, LLC | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Novo Nordisk Inc | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
Products named: Korlym, INSPIRE, LEQVIO, OTEZLA, TRELEGY ELLIPTA, Rybelsus, BREZTRI, Dexcom G6 Transmitter.
Industry payments across VA — which companies pay providers there.
